Zolpidem and Temovate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zolpidem (zolpidem tartrate) and Temovate (clobetasol propionate). Common drug interactions include abdominal pain among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Zolpidem and Temovate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Zolpidem?
Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.
What is Temovate?
Temovate has active ingredients of clobetasol propionate. eHealthMe is studying from 1,392 Temovate users. Check the latest studies of Temovate.
12 people who take Zolpidem and Temovate together, and have interactions are studied.

What are the common drug interactions of Zolpidem and Temovate, by gender? *:
female:
- Abdominal pain
- Anaemia (lack of blood)
- Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
- Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
- Cough
- Delirium (wild excitement)
- Fatigue (feeling of tiredness)
- Pyrexia (fever)
- Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
- Weight increased
male:
- Abdominal pain
- Constipation
- Secondary hyperthyroidism
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
- White blood cell count decreased
- Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium)
- Pain
- Bacteraemia (presence of bacteria in the blood)
- Chronic kidney disease
What are the common drug interactions of Zolpidem and Temovate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Abdominal pain
- Acne (skin problems that cause pimples)
- Cough
- Fatigue (feeling of tiredness)
- Injection site pain
- Nasal discomfort
- Nausea (feeling of having an urge to vomit)
- Pruritus (severe itching of the skin)
- Respiratory tract infection
- Vitamin b1 deficiency
40-49:
- Abdominal pain
- Constipation
- Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium)
- Pain
- Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
- Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
- Delirium (wild excitement)
- Pyrexia (fever)
- Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
- Chronic kidney disease
50-59:
- Anaemia (lack of blood)
- Abdominal pain
- Back pain
- Dyspnoea (difficult or laboured respiration)
- Headache (pain in head)
- Hypokalaemia (low potassium)
- Oral herpes (viral infection of mouth)
- Psoriasis (immune-mediated disease that affects the skin)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Rash
60+:
- Abdominal pain upper
- Anxiety
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hypoacusis (loss of hearing)
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Renal failure (kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
- Weight increased
- White blood cell count decreased
What are the existing conditions these people have? *
- Pain: 5 people, 41.67%
- High Blood Pressure: 4 people, 33.33%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 25.00%
- Muscle Aches (muscle pain): 2 people, 16.67%
- Constipation: 2 people, 16.67%
- Depression: 2 people, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
- Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 2 people, 16.67%
- Stress And Anxiety: 2 people, 16.67%
- Muscle Spasms (muscle contraction): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Zolpidem and Temovate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Zolpidem and Temovate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zolpidem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Temovate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zolpidem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Temovate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on zolpidem tartrate and clobetasol propionate (the active ingredients of Zolpidem and Temovate, respectively), and Zolpidem and Temovate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zovirax cause Heart Rate Increased? - 4 seconds ago
- Drug interactions of Sodium Bicarbonate and Narcan - 5 seconds ago
- Could Alendronic Acid cause Syncope Aggravated? - 11 seconds ago
- Could Flonase cause Hand Dermatitis? - 13 seconds ago
- Could Hyzaar cause Bladder Mass? - 14 seconds ago
- How effective is Imipramine Hydrochloride for Stress And Anxiety? - 16 seconds ago
- Could Hytrin cause Breathing - Slowed Or Stopped? - 17 seconds ago
- Could Naglazyme cause Fainting? - 20 seconds ago
- Could Levothyroxine Sodium cause Optic Nerve Disorder? - 26 seconds ago
- Could Aldactone cause Renal Injury? - 27 seconds ago